Healthy Aging Health Center
This article is from the WebMD News Archive
Living Longer: Life Expectancy Hits New High
Sept. 12, 2007 -- Life expectancy is greater than ever in the U.S., hovering a smidge below 78 years, the CDC today announced.
But America's lengthier life span still lags behind life expectancy in dozens of countries, according to World Health Organization statistics.
A baby born in the U.S. in 2005 has a life expectancy of 77.9 years. That's an extra tenth of a year, compared to life expectancy in 2004, according to the CDC's life expectancy statistics.
The CDC also reports that the top three causes of death -- heart disease, cancer, and stroke -- declined in 2005, compared with 2004, leading to greater life expectancy. However, heart disease, cancer, and stroke remain the country's top killers.
The life expectancy statistics are based on the CDC's preliminary data on more than 2.4 million deaths nationwide in 2005.
Life Expectancy Details
Life expectancy continues to be greater for women than for men and for whites compared with African-Americans -- but life expectancy edged up enough to reach a record high for African-Americans.
Here are the life expectancies for girls and boys born in 2005:
- White girl: 80.8 years (unchanged from 2004)
- White boy: 75.7 years (unchanged from 2004)
- African-American girl: 76.5 years (up from 76.3 years in 2004)
- African-American boy: 69.6 years (up from 69.5 years in 2004)
However, 26 countries have higher life expectancies for both men and women, according to the World Health Organization.
Japan has the world's greatest life expectancy for women (86 years) and the European republic of San Marino has the world's greatest life expectancy for men (80 years), according to the World Health Organization.
Top Causes of Death
The top 15 causes of death for 2005 are as follows:
- Heart disease
- Cancer
- Stroke
- Chronic lower respiratory diseases (lung diseases)
- Accidents
- Diabetes
- Alzheimer's disease
- Influenza and pneumonia
- Kidney disease
- Septicemia (a serious infection that affects the blood and other parts of the body)
- Suicide
- Chronic liver disease and cirrhosis
- High blood pressure
- Parkinson's disease
- Homicide
In 2005, heart disease killed 210.3 per 100,000 people, down from 217 per 100,000 in 2004.
Cancer deaths dropped from 185.8 per 100,000 people in 2004 to 183.8 per 100,000 in 2005. Stroke killed 50 per 100,000 people in 2004, compared with 46.6 per 100,000 in 2005.
Top Causes of Infant Death
The infant mortality rate for 2005 was 6.89 infant deaths per 1,000 live births. That's up from 6.79 infant deaths per 1,000 live births in 2004, but that difference may have been due to chance, notes the CDC.
Once again, there was a race gap in the infant mortality rate (which includes deaths within the first year after birth).
For whites, the infant mortality rate was 5.76 infant deaths per 1,000 live births (up from 5.66 infant deaths per 1,000 live births in 2004). For African-Americans, the infant mortality rate was 13.69 infant deaths per 1,000 live births (down from 13.79 infant deaths per 1,000 live births in 2004).
The top 10 causes of infant mortality for 2005 are as follows:
- Birth defects
- Low birth weight
- Sudden infant death syndrome (SIDS)
- Maternal complications
- Placenta, cord, and membrane complications
- Accidents
- Respiratory distress in newborns
- Bacterial sepsis in newborns (a bacterial infection that affects the blood and other parts of the body)
- Neonatal hemorrhage (bleeding)
- Necrotizing enterocolitis in newborns (serious intestinal disease)
The life expectancy and death statistics are posted on the CDC's web site.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


